Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period	STARTED	Pimecrolimus	1,205
Treatment Period	STARTED	Topical Corticosteroids	1,213
Treatment Period	COMPLETED	Pimecrolimus	836
Treatment Period	COMPLETED	Topical Corticosteroids	874
Treatment Period	NOT COMPLETED	Pimecrolimus	369
Treatment Period	NOT COMPLETED	Topical Corticosteroids	339
Follow-Up Period	STARTED	Pimecrolimus	120
Follow-Up Period	STARTED	Topical Corticosteroids	70
Follow-Up Period	COMPLETED	Pimecrolimus	90
Follow-Up Period	COMPLETED	Topical Corticosteroids	46
Follow-Up Period	NOT COMPLETED	Pimecrolimus	30
Follow-Up Period	NOT COMPLETED	Topical Corticosteroids	24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00120523/flow